Forward Engineering Organ Development and Cancer Therapeutics with Optogenetics

Area of Science:

• Developmental Biology
• Optogenetics
• Cell Signaling

Background:

• Robust organ growth control is vital for survival, and its dysregulation leads to diseases like cancer.
• Understanding precise organ size regulation mechanisms remains a significant challenge.
• Optogenetic tools offer noninvasive methods to control cellular signaling in vivo.

Purpose of the Study:

• To investigate how bioelectrical and chemical cues regulate organ growth using optogenetics.
• To explore the role of intracellular calcium signaling in Drosophila wing development.
• To determine if optical stimulation parameters can control organ size and tumor morphology.

Main Methods:

• Utilized the red-light-activated channelrhodopsin, CsChrimson, in the Drosophila melanogaster wing epithelium.
• Systematically varied light intensity and activation dynamics to stimulate intracellular calcium signaling.
• Developed a computational model to explain calcium dynamics, incorporating gap junction and voltage-gated calcium channel activity.
• Co-expressed CsChrimson with the oncogene RasV12 to study tumorous tissue response.

Main Results:

• Identified a biphasic regulation of organ size based on light stimulation parameters.
• Demonstrated that specific light patterns (dim, pulsatile) promote organ growth and cell proliferation.
• Showed that intense, prolonged light induces cell death and morphological abnormalities.
• Confirmed that optical stimulation can modulate tumorous tissue morphology and growth.

Conclusions:

• Precise control of cellular calcium signaling via optogenetics can dynamically regulate organ size.
• The findings provide a framework for dissecting physiological signaling in organogenesis.
• This approach offers potential translational insights for cancer therapy and regenerative medicine.